Reporting season ends with relief over optimism

Corporate Australia wrapped its first half of FY26 reporting season with earnings that met expectations, yet investor confidence remained thin. The market’s reaction was driven more by the absence of disaster than by solid profit upgrades, a pattern that surfaced across the ASX300.

Growth numbers hide uneven performance

The ASX300’s FY26 earnings are on track for roughly 12% year‑on‑year growth, the strongest pace in three years. Removing mining and energy lowers that figure to about 5.1%, and stripping out financials reduces it further to close to 1‑2% for the rest of the corporate environment.

Of the 197 companies that have reported, 32% beat consensus earnings by more than 5%, while 16% missed by a similar margin. The beat‑to‑miss ratio looks respectable, but the guidance outlook tells a different story.

Only 18% of firms lifted FY27 guidance above market forecasts, whereas 30% trimmed expectations and the remainder kept guidance unchanged. The modest earnings surprise of 0.15% came despite a sales shortfall, with margins buoyed by lower input costs and a more favourable product mix.

Guidance trends signal caution

Analysts downgraded aggregate earnings for FY26 and FY27 by 1‑2% during the season, with three companies receiving cuts for every two that were upgraded. The technology, other materials and financial services sectors saw the few upgrades, while utilities, metals and mining and energy faced the steepest downgrades.

Sector‑level earnings momentum has flipped from the February results window, moving from upward EPS pressure to a broader wave of downward revisions. Despite this, consensus still projects reasonable FY26 growth, though expectations for FY27 are softer amid weaker trading updates.

Healthcare and materials stocks posted the strongest share‑price gains, while domestic‑focused financials, REITs and consumer discretionary lagged. The rally in materials reflected earlier earnings upgrades, but that support is waning as commodity tailwinds fade.

Healthcare’s lift outpaced its earnings, with CSL and Cochlear posting results largely in line with forecasts. Their share moves appear to stem more from relief that performance wasn’t worse than anticipated rather than from a genuine earnings upgrade.

UBS research captures this relief‑rally pattern: among non‑resource stocks that jumped over 5% on results, 27 of 37 did so because outcomes were less negative than feared. Those stocks rallied an average of 12% post‑report, yet they started the year down more than 20%, leaving them still down over 12% year‑to‑date.

The consumer‑facing segment showed the opposite trend. Companies such as Temple & Webster, JB Hi‑Fi and Premier reported disappointing trading updates, reflecting a slowdown in domestic spending driven by housing‑affordability strain, high interest rates and a softening labour market. Wage growth remains near 6% year‑on‑year, keeping inflation pressures alive.

While consumer demand eases, business‑related areas like lending, infrastructure, defence, mining services and data‑centre investment held steady through the reporting window. This suggests the economy is not in a broad contraction but is increasingly split between consumer‑driven and business‑driven activity.

From a practical standpoint, investors should treat the rally in lagging stocks as a temporary bounce rather than a sign of a lasting turnaround. The underlying earnings revisions remain modest, and many of those companies still carry significant downside risk if the broader consumer environment does not improve.

In summary, the reporting season delivered solid headline earnings but left investors wary. The market rewarded companies that avoided the worst‑case scenarios, yet the underlying earnings outlook has tilted lower, especially for FY27. Firms that can convert higher capital spending and AI investment into tangible profit growth may emerge as the true beneficiaries in the months ahead.